Insider Trading & Ownership - Fairmount Funds Management LLC

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Fairmount Funds Management LLC
Goto Prev, 0, 1
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-07-13
Purchase
2023-07-17
8:00 pm
Apogee Therapeutics Inc. APGE Fairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest II L.P.
Kiselak Tomas
Harwin Peter Evan
Director
2,941,176 $17 $49,999,992 988,045
(Indirect
Direct)
View
2023-06-09
Purchase
2023-06-13
4:07 pm
Cogent Biosciences Inc. COGT Fairmount Funds Management LLC
See Remarks
10% Owner
800,000 $12 $9,600,000 3,626,389
(Indirect)
View
2022-08-17
Purchase
2022-08-19
4:32 pm
Viridian Therapeutics Inc. VRDN Fairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
See Remarks
10% Owner
425,531 $23.5 $9,999,979 1,369,623
(Indirect)
View
2022-06-16
Purchase
2022-06-21
10:02 am
Cogent Biosciences Inc. COGT Fairmount Funds Management LLC
See Remarks
10% Owner
1,200,000 $8.25 $9,900,000 2,826,389
(Indirect)
View
2021-09-21
Purchase
2021-09-23
09:30 am
Viridian Therapeutics Inc. VRDN Fairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Director
10% Owner
909,000 $11 $9,999,000 1,077,283
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-07-13
Option Award
2023-07-17
8:00 pm
N/A
2033-07-13
Apogee Therapeutics Inc. APGE Fairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest II L.P.
Kiselak Tomas
Harwin Peter Evan
Director
95,516 $0 988,045
(Direct)
View

Ownership
2023-07-13
6:39 pm
N/A
N/A
Apogee Therapeutics Inc. APGE Fairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Director
0 $0 6,743,321
(Indirect)
View

Ownership
2023-06-30
5:32 pm
N/A
N/A
Aeglea BioTherapeutics Inc. AGLE Fairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
0 $0 536,284,540
(Indirect)
View

Ownership
2020-10-30
11:43 am
N/A
N/A
MIRAGEN THERAPEUTICS INC. MGEN Fairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
See Remarks
0 $0 131,717,393
(Indirect)
View
2020-10-27
Other
2020-10-29
11:30 am
N/A
N/A
MIRAGEN THERAPEUTICS INC. MGEN Fairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
See Remarks
625,247 $0 1,063,749
(Indirect)
View
Goto Prev, 0, 1